首页 | 本学科首页   官方微博 | 高级检索  
     

回生口服液对老年肿瘤患者化疗后细胞免疫功能的影响
引用本文:马冬,林萍,邓罡. 回生口服液对老年肿瘤患者化疗后细胞免疫功能的影响[J]. 成都中医药大学学报, 2005, 28(3): 52-54
作者姓名:马冬  林萍  邓罡
作者单位:广东省人民医院,肿瘤中心,广东,广州,510010;广东省老年医学研究所,广东,广州,510080
摘    要:目的观察回生口服液对老年肿瘤患者细胞免疫功能的影响.方法将62例老年肿瘤患者,分为两组:观察组(常规化疗加回生口服液)30例,对照组(常规化疗)32例.观察组依据原发肿瘤的常规化疗2周期,自化疗开始予回生口服液10 mL tid持续8周,对照组依据原发肿瘤常规化疗2周期.结果治疗后观察组较对照组细胞免疫功能明显改善,两组相比有显著差异(P<0.05),化疗前后粒细胞减少治疗组发生率为21.7%(13/60),对照组发生率为40.6%(26/64),两组比较有统计学意义(P<0.05).结论回生口服液能改善老年肿瘤患者机体的细胞免疫活性,减轻化疗的血液毒性,对老年肿瘤患者的辅助治疗有益处.

关 键 词:回生口服液  老年肿瘤患者  化疗  细胞免疫功能
文章编号:1004-0668(2005)03-0052-03
收稿时间:2005-01-27
修稿时间:2005-01-27

Influence on Hui- sheng oral liquid to Cellular Immunity Function of Aged Cancer Patients after Chemotherapy
MA Dong,LIN Ping,DENG Gang. Influence on Hui- sheng oral liquid to Cellular Immunity Function of Aged Cancer Patients after Chemotherapy[J]. Journal of Chengdu University of Traditional Chinese Medicine, 2005, 28(3): 52-54
Authors:MA Dong  LIN Ping  DENG Gang
Abstract:Objective: To explore the effect of the Hui-sheng oral liquid for the cellular immunity function on aged cancer patients. Methods: Sixty-two aged cancer patients were enrolled in this study. They were divided into test group (30 cases) and control group(32 cases) .The test group received chemotherapy combing Hui-sheng oral liquid and the control group received the chemotherapy alone. Result: The cellular immunity function was improved and the hematologi-cal toxicity of chemotherapy was reduced in test group( P < 0.05), there being a statistically significant difference. Conclusion:The Hui-sheng oral liquid could lower the influence on cellular immunity function and toxic reaction of chemotherapy. It is beneficial for aged cancer patients.
Keywords:Hui - sheng oral liquid   aged cancer patients   chemotherapy   cellular immunity function
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号